Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 4 of 4 drugs
| No. | DrugBank | 薬物名（臨床試験情報から抽出） | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Dabigatran | 1件: Dabigatran Dabigatran | 1件: Dabigatran
Dabigatran
💬1. Dabigatran
| 1件: F2 F2 💬1. Dabigatran
| 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor ... | 5件: 51 51, 75, 85, 91, 124 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Gold | 1件: Gold Gold | - | - | - | 43件: 2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318 💬 43件: 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 11 ... 2. Gold
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Rivaroxaban | 2件: RIVAROXABAN RIVAROXABAN; Xarelto | 1件: Rivaroxaban
Rivaroxaban
💬3. Rivaroxaban
| 1件: F10 F10 💬3. Rivaroxaban
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 4件: 46 46, 49, 91, 210 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Warfarin | 2件: Warfarin Warfarin; Warfarin Sodium | 1件: Warfarin
Warfarin
💬4. Warfarin
| 2件: NQO1 NQO1,VKORC1 💬 | 7件: Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress ... | 11件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91 💬4. Warfarin
|